Table 1. χ2 test of the association between clinicopathologic parameters and Glo1 expression using the TCGA dataset.
Clinical and pathological factor | Glo1low | Glo1high | p value | |
---|---|---|---|---|
Primary tumor | ||||
T1 | 36 | 60 | 0.18 | |
T2-4 | 160 | 195 | ||
Regional lymph nodes | ||||
N0 | 97 | 119 | 0.61 | |
N1-4 | 96 | 130 | ||
Distant metastasis | ||||
M0 | 189 | 238 | 0.057 | |
M1 | 2 | 10 | ||
Tumor stage | ||||
Stage I-II | 125 | 167 | 0.053 | |
Stage III-IV | 34 | 72 | ||
Estrogen receptor status | ||||
Negative | 43 | 52 | 0.052 | |
Positive | 93 | 180 | ||
Progesterone receptor status | ||||
Negative | 54 | 90 | 0.83 | |
Positive | 83 | 145 | ||
ERBB2 status | ||||
Negative | 98 | 130 | 0.37 | |
Positive | 27 | 46 |